Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients

Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients

IntroductionKidney transplant recipients (KTRs) are at high risk of severe COVID-19, even when they are fully vaccinated. Additional booster vaccinations or passive immunization with prophylactic monoclonal antibodies are recommended to increase their protection against severe COVID-19.MethodsHere,...

Full description

Bibliographic Details
Main Authors:	Valérie Moal, Margaux Valade, Céline Boschi, Thomas Robert, Nicolas Orain, Audrey Bancod, Sophie Edouard, Philippe Colson, Bernard La Scola
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Microbiology
Subjects:	SARS-CoV-2 COVID-19 kidney transplantation immunocompromized vaccine tixagevimab
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1147455/full

Similar Items

Incidental diagnosis of mpox virus infection in patients undergoing sexually transmitted infection screening—findings from a study in France
by: Sophie Edouard, et al.
Published: (2024-06-01)

High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2
by: Rita Jaafar, et al.
Published: (2021-10-01)

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
by: Celine Boschi, et al.
Published: (2022-12-01)

Matrix-Encoding Gene Diversity of 624 Influenza A/H3N2 Genomes Does Not Show Association with Impaired Viral Detection by Commercialized qPCR Assays
by: Lorlane Le Targa, et al.
Published: (2022-11-01)

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
by: Daria S. Fomina, et al.
Published: (2023-10-01)

Water- borne protozoan parasitic infections
by: J. S. Edirisinghe
Published: (2002-12-01)

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
by: Andrea Lombardi, et al.
Published: (2023-05-01)

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
by: Daniele Focosi, et al.
Published: (2022-09-01)

Temporal Shift of the Respiratory Syncytial Virus Epidemic Peak for the Years 2020–2023 in Marseille, Southern France
by: Lucille Claire De Maria, et al.
Published: (2023-07-01)

Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis
by: A. C. Lehur, et al.
Published: (2017-05-01)

Species Diversity, Molecular Characterization, and Antimicrobial Susceptibility of Opportunistic Actinomycetes Isolated from Immunocompromised and Healthy Patients of Markazi Province of Iran
by: Azadi D, et al.
Published: (2020-01-01)

Immunoenhancement effects of pentadecapeptide derived from Cyclina sinensis on immune-deficient mice induced by Cyclophosphamide
by: Fangmiao Yu, et al.
Published: (2019-09-01)

COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis
by: Saartje Demolder, et al.
Published: (2024-01-01)

Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-CoV-2 in End-Stage Renal Disease Patients on Chronic Hemodialysis: A Single-Center Study
by: Mohammed Kamal Nassar, et al.
Published: (2023-12-01)

Current State of the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplantation
by: Sabina Herrera, et al.
Published: (2019-01-01)

Choosing a cellular model to study SARS-CoV-2
by: Gabriel Augusto Pires De Souza, et al.
Published: (2022-10-01)

Isolation of Viable SARS-CoV-2 Virus from Feces of an Immunocompromised Patient Suggesting a Possible Fecal Mode of Transmission
by: Julie Dergham, et al.
Published: (2021-06-01)

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients
by: Cesare Ernesto Maria Gruber, et al.
Published: (2023-10-01)

Simple Wastewater Preparation Protocol Applied to Monitor the Emergence of the Omicron 21L/BA.2 Variant by Genome Sequencing
by: Nathalie Wurtz, et al.
Published: (2023-01-01)

Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells
by: Gabriel Augusto Pires de Souza, et al.
Published: (2021-12-01)

Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19
by: Nicolina Capoluongo, et al.
Published: (2023-10-01)

Description of Virulent Factors and Horizontal Gene Transfers of Keratitis-Associated Amoeba Acanthamoeba Triangularis by Genome Analysis
by: Issam Hasni, et al.
Published: (2020-03-01)

Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies
by: Vladimir N. Antonov, et al.
Published: (2023-04-01)

First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
by: Philippe Colson, et al.
Published: (2022-09-01)

Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France
by: Audrey Giraud-Gatineau, et al.
Published: (2020-07-01)

Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France
by: Nadim Cassir, et al.
Published: (2022-12-01)

The analysis of translation-related gene set boosts debates around origin and evolution of mimiviruses.
by: Jônatas Santos Abrahão, et al.
Published: (2017-02-01)

Limited permissibility of ENL-R and Mv-1-Lu mink cell lines to SARS-CoV-2
by: Marion Le Bideau, et al.
Published: (2022-10-01)

Clustered Cases of Rickettsia sibirica mongolitimonae Infection, France
by: Sophie Edouard, et al.
Published: (2013-02-01)

Evidence of a Cellulosic Layer in Pandoravirus massiliensis Tegument and the Mystery of the Genetic Support of Its Biosynthesis
by: Djamal Brahim Belhaouari, et al.
Published: (2019-12-01)

Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates
by: Celine Boschi, et al.
Published: (2021-12-01)

Quasispecies Analysis of SARS-CoV-2 of 15 Different Lineages during the First Year of the Pandemic Prompts Scratching under the Surface of Consensus Genome Sequences
by: Wahiba Bader, et al.
Published: (2022-12-01)

Identification of giant Mimivirus protein functions using RNA interference
by: Haitham eSobhy, et al.
Published: (2015-04-01)

Giant viruses of amoebas: an update
by: Sarah eAherfi, et al.
Published: (2016-03-01)

Bartonella henselae in Skin Biopsy Specimens of Patients with Cat-Scratch Disease
by: Emmanouil Angelakis, et al.
Published: (2010-12-01)

SARS-CoV-2 Testing of Aircraft Wastewater Shows That Mandatory Tests and Vaccination Pass before Boarding Did Not Prevent Massive Importation of Omicron Variant into Europe
by: Lorlane Le Targa, et al.
Published: (2022-07-01)

The efficacy of tixagevimab/cilgavimab (Evusheld) in prophylaxis and treatment of COVID-19 in immunocompromised patients: a systematic review and meta-analysis
by: Shaymaa Glhoom, et al.
Published: (2024-01-01)

Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis
by: Luke B. Elias, et al.
Published: (2023-12-01)

Editorial: Covid-19 therapies in patients with hematologic malignancies
by: Andrea Visentin, et al.
Published: (2024-02-01)

Virophages of Giant Viruses: An Update at Eleven
by: Said Mougari, et al.
Published: (2019-08-01)